CARNUCCIO, ROSA
 Distribuzione geografica
Continente #
EU - Europa 5.626
AS - Asia 5.338
NA - Nord America 5.153
SA - Sud America 552
Continente sconosciuto - Info sul continente non disponibili 201
AF - Africa 125
OC - Oceania 10
Totale 17.005
Nazione #
US - Stati Uniti d'America 4.943
IT - Italia 2.483
SG - Singapore 2.469
RU - Federazione Russa 1.507
CN - Cina 945
VN - Vietnam 916
BR - Brasile 435
HK - Hong Kong 421
FR - Francia 257
NL - Olanda 235
UA - Ucraina 213
DE - Germania 196
FI - Finlandia 190
IE - Irlanda 173
CA - Canada 129
IN - India 120
GB - Regno Unito 115
JP - Giappone 105
BD - Bangladesh 72
SE - Svezia 69
AR - Argentina 50
MX - Messico 43
ZA - Sudafrica 39
TR - Turchia 36
PL - Polonia 34
ES - Italia 30
IQ - Iraq 30
TH - Thailandia 26
PK - Pakistan 24
PH - Filippine 23
ID - Indonesia 22
CH - Svizzera 21
EC - Ecuador 21
KR - Corea 21
CI - Costa d'Avorio 18
IR - Iran 17
CZ - Repubblica Ceca 15
TW - Taiwan 15
LT - Lituania 12
TN - Tunisia 12
CO - Colombia 11
JM - Giamaica 11
EG - Egitto 10
RS - Serbia 10
AT - Austria 9
NP - Nepal 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
MA - Marocco 8
PY - Paraguay 8
UZ - Uzbekistan 8
JO - Giordania 7
KE - Kenya 7
RO - Romania 7
UY - Uruguay 7
AL - Albania 6
BE - Belgio 6
DZ - Algeria 6
GR - Grecia 6
GT - Guatemala 6
KZ - Kazakistan 6
LU - Lussemburgo 6
CL - Cile 5
MY - Malesia 5
PE - Perù 5
VE - Venezuela 5
MD - Moldavia 4
NO - Norvegia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BF - Burkina Faso 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
IL - Israele 3
PS - Palestinian Territory 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BS - Bahamas 2
GF - Guiana Francese 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
MN - Mongolia 2
NI - Nicaragua 2
QA - Qatar 2
RW - Ruanda 2
SI - Slovenia 2
TG - Togo 2
UG - Uganda 2
AO - Angola 1
BY - Bielorussia 1
BZ - Belize 1
Totale 16.781
Città #
Singapore 1.096
San Jose 840
Hong Kong 403
Chandler 364
Ashburn 354
Moscow 350
Beijing 304
Ho Chi Minh City 262
Jacksonville 206
The Dalles 200
Hanoi 199
Millbury 186
Princeton 163
Santa Clara 151
Naples 146
Lauterbourg 141
Rome 135
Amsterdam 115
Nanjing 113
Los Angeles 110
Boston 99
Seattle 98
Tokyo 94
Wilmington 84
Buffalo 82
Milan 78
New York 76
Napoli 57
Dallas 54
Woodbridge 52
Ottawa 50
Council Bluffs 48
Munich 44
Cagliari 42
São Paulo 42
Da Nang 40
Redondo Beach 40
Florence 37
Bologna 35
Orem 34
Haiphong 33
Brooklyn 32
Nanchang 32
Hebei 30
Montreal 30
Tianjin 29
Bari 28
Shenyang 27
Turin 26
Warsaw 26
Biên Hòa 22
Catania 22
Des Moines 22
Houston 22
Chennai 21
Chicago 21
Hefei 21
San Francisco 21
Ann Arbor 20
London 20
Denver 19
Salerno 19
Palermo 18
Pune 18
Changsha 17
Falls Church 17
Ferrara 17
Kronberg 17
Mexico City 17
Norwalk 17
Catanzaro 16
Dong Ket 16
Frankfurt am Main 16
Toronto 16
Turku 16
Jiaxing 15
Brescia 14
Brno 14
Bangkok 13
Caserta 13
Hải Dương 13
Mumbai 13
Verona 13
Atlanta 12
Helsinki 12
Manchester 12
Baghdad 11
Boardman 11
Johannesburg 11
New Delhi 11
Padova 11
Rio de Janeiro 11
Shanghai 11
Zurich 11
Curitiba 10
Orange 10
Phoenix 10
Poplar 10
Torino 10
Can Tho 9
Totale 8.076
Nome #
Etosomi e transferosomi per la veicolazione topica del resveratrolo. 2.049
Etosomi e transferosomi per la veicolazione topica del resveratrolo 607
Sviluppo di nuovi gel fisici a base di chitosano per il trattamento di piaghe da decubito. 180
Ruolo dei fattori trascrizionali NF-kB, IRF-1 e STAT1 nell’induzione del gene della iNOS da parte di gliadina ed IFN- in macrofagi RAW 264.7 178
Transferosomes and ethosomes for the trans-resveratrol permeation through the skin: a comparative study. 170
Novel Non-Peptide Small Molecules Preventing IKKβ/NEMO Association Inhibit NF-κB Activation in LPS-Stimulated J774 Macrophages 157
Design and characterization of a chitosan physical gel promoting wound healing in mice. 151
Transcription factor decoy oligonucleotides to nuclear factor-κB inhibits reverse passive Arthus reaction in rat. 139
Adenosine A2A Receptor Agonist, 2-p-(2-Carboxyethyl)phenethylamino-5′-N-ethylcarboxamidoadenosine hydrochloride hydrate (CGS21680), Inhibits Inflammation and Increases Fibroblast Growth Factor 2 (FGF-2) Tissue Expression in Carrageenan Induced Rat Paw Edema. 138
Biodegradable particles for local and prolonged delivery of an oligonucleotide decoy to nuclear factor-kB in the lung 137
NF-kappaB regulates cell survival in chronic granulomatous inflammation. 135
Role of nuclear factor-kappaB in a rat model of vascular injury. 134
BIOACTIVE PHYSICAL CHITOSAN-BASED GELS FOR WOUND HEALING 134
Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. 130
Delivery of a decoy oligonucleotide against NF-??B by new cationic liposomes 130
Development of new physical gels based on chitosan for wound healing. 128
Effect of Hyaluronic Acid on the Thermogelation and Biocompatibility of its blends with Methyl Cellulose 128
In situ forming gel fo wound healing 127
Improving therapy of lung inflammation by inhalable powders for prolonged release of a decoy oligonucleotide against NF-kB 126
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator 124
5,6-Dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolysaccharide-induced production of nitric oxide by J774 macrophages 123
Structure and absolute stereochemistry of the new cyclolinteinol and cyclolinteinol acetate, macrophage activation modulators 121
The IkB Kinase Inhibitor, NEMO-binding Domain Peptide, inhibits rat balloon injury-induced neointimal formation. 119
Gliadina ed espressione del gene della iNOS: ruolo di NF-kB, IRF-1 e STAT-1 alfa. 118
Anti-inflammatory activity of macrolide antibiotics. 118
Development of new physical gels based on chitosan for wound healing. 116
Neutralization of IL-18 inhibits balloon-injury-induced neointimal formation. 113
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator. 113
Enhanced antioxidant effect of trans-resveratrol: potential of binary systems with polyethylene glycol and cyclodextrin. 112
Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation 111
Neutralization of Interleukin-18 Inhibits Neointimal Formation in a Rat Model of Vascular Injury. 111
The role of NF-kappaB, IRF-1, STA-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. 111
Nanocarriers for topical administration of resveratrol: a comparative study 111
Neutralization of IL-18 inhibits injury-induced neointima formation. 110
A new antiproliferative sulfated alkene from the mediterranean tunicate Microcosmus vulgaris 110
Respirable large porous particles for local and prolonged delivery of an oligonucleotide decoy to Nuclear Factor-kB: in vitro/in vivo potential in cystic fibrosis 110
The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. 110
LIPOCORTIN AND VASOCORTIN: TWO SPECIES OF GLUCOCORTICOID INDUCED PROTEINS AFFECTING VASCULAR PERMEABILITY. 108
Nuovi liposomi cationici per la veicolazione di oligonucleotidi. 107
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis 107
Nitric oxide-induced endoplasmic reticulum stress activates the expression of cargo receptor proteins and alters the glycoprotein transport to the Golgi complex 106
Inhibition of nuclear factor-kB activation prevents the loss of vascular tone in LPS-treated rats. 105
Novel chitosan gel for wound healing: thermal, rheological, in vitro drug release and biocompatibility properties 105
Macrophage Autophagy in Atherosclerosis 104
Oxalomalate affects the inducible nitric oxide synthase expression and activity 102
The IkB kinase inhibitor nuclear factor-kB essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation. 102
Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid artery. 101
Transferosomes and ethosomes for the trans-resveratrol permeation through the skin: a comparative study 101
Inhalable large porous particles for local and prolonged devlivery an oligonucleotide decoy to NF-??B in cystic fibrosis 101
PEI-Engineered Respirable Particles Delivering a Decoy Oligonucleotide to NF-kB: Inhibiting MUC2 Expression in LPS-Stimulated Airway Epithelial Cells 101
Inhibition of iNOS protein expression by decoy ODN against NF-kappaB released from PLGA microspheres and naked ODN in activated macrophages. 100
NF-kappaB is activated in intestinal mucosa of coeliac patients. 99
Control of autophagy by oncogenes and tumor suppressor genes 99
A new approach for cystic fibrosis treatment: large porous particles for local and prolonged delivery of an oligonucleotide decoy to Nuclear Factor-kB in the lung 98
Porrigenins A and B, novel cytotoxic and antiproliferative sapogenins isolated from Allium porrum 96
Synthesis and Pharmacological Evaluation of Modified Adenosines Joined to Mono-Functional Platinum Moieties 96
Palmitoylethanolamide controls rMCP-5 activity by the regulation of microphtalmia-associated transcription factor. 95
Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occurin LPS-induced plasma leakage in rat skin 94
Activation of nuclear transcription factor kappaB in rat carrageenin-induced pleurisy. 94
Novel antiproliferative Alkyl sulfates from the Mediterranean tunicate Ascidia mentula 93
Ultraflexible liposomes for topical delivery of resveratrol 93
Inhibition of NF-kappaB activation by decoy ODN released from liposomes in activated macrophages. 93
Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres. 92
Characterization of vasocortin-like proteins induced by dexamethasone in endothelial cells. 92
PLGA microspheres for the delivery of oligonucleotides. 92
Nanocarriers for topical delivery of resveratrol. 92
Transcription factor decoy oligodeoxynucleotides to nuclear factor-kappaB inhibits reverse passive Arthus reaction in rat. 91
Antihistaminic activity of the alkaloids isolated from Caribbean Agelas sponges. 90
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement 90
Effects of Hydroxytyrosol on Macrophage Activation 90
Engineering inhalable particles for local and prolonged delivery of an oligonucleotide decoy to nuclear factor-kb 90
. Liposomi a base di un nuovo lipide cationico per il rilascio di un oligonucleotide decoy contro il fattore di trascrizione NF-kappaB. 90
12-Keto-Porrigenin and the Unique 2,3-Seco-Porrigenin, New Antiproliferative Sapogenins isolated from Allium porrum. 88
Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-??B delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells. 88
Microsfere di PLGA per il rilascio controllato di un oligonucleotide decoy per NF-kappaB. 88
Activation of nuclear factor-kB in rat carrageenin-induced pleurisy. 87
NFkappaB decoy oligonucleotides. 87
Antiproliferative sesterterpenes from the Caribbean sponge Cacospongia cf. linteiformis. 87
NF-kB decoy ODN released from respirable and biodegradable PEI/PLGA particles inhibits MUC2 expression in LPS-stimulated human lung cells 87
Cyclolinteinone, a sesterterpene from sponge Cacospongia linteiformis, prevents inducible nitric oxide synthase and inducible cyclo-oxygenase protein expression by blocking nuclear factor-kappaB activation in J774 macrophages. 86
The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells 86
Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat. 86
Microspheres for the sustained release of an ODN decoy to NF-kB in rat model of chronic inflammation 86
A Decoy Oligonucleotide to NF-κB Delivered through Inhalable Particles Prevents LPS-Induced Rat Airway Inflammation. 86
Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. 85
Novel physical chitosan gel: in vivo evidence of its potential in wound healing 85
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation 85
L'agelongina inibisce la produzione di NO e l'espressione della iNOS in cellule di glioma di ratto C6 stimolate con LPS ed IFN-gamma 84
Nuclear factor-kappaB is activated in small intestinal mucosa of celiac patients. 83
INVOLVEMENT OF NF-KB IN THE REGULATION OF CYCLOOXIGENASE-2 PROTEIN EXPRESSION IN LPS-STIMULATED J774 MACROPHAGES. 83
Nuclear factor-kB activation mediates the expression of inducible isoforms of nitric oxide synthase and cyclooxygenase in a rat model of vascular injury. 83
Novel particulate systems for the delivery of an oligonucleotide decoy to Nuclear Factor-kappaB: a potential strategy for treating cystic fibrosis 83
Different strategy for an efficient delivery of an oligonucleotide decoy to NF-kappaB. 83
Differential effect of L-NAME and S-methyl-isothiourea on leukocyte emigration in carrageenin-soaked sponge implants in rat. 82
Nuclear factor-kB activation mediates inducible nitric oxide synthase expression in carrageenin-induced pleurisy. 81
Regulation of autophagy by cytoplasmic p53 81
Polyethylenimine-engineered respirable particles delivering a decoy oligonucleotide to NF-B: a novel combination therapy for cystic fibrosis? PROGEJT FFC#23_2011 81
Nanomaterials toxicity and cell death modalities. 81
A decoy oligonucleotide to NF-κB delivered through inhalable particles inhibits the lung inflammation induced by LPS in rat 81
Lipocortins 80
Totale 12.911
Categoria #
all - tutte 54.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.052 0 9 22 29 16 35 41 53 198 105 140 404
2022/20231.152 195 104 42 73 120 95 35 107 127 118 80 56
2023/20241.152 54 100 149 76 66 119 65 144 30 41 227 81
2024/20253.869 299 161 42 99 128 177 469 231 319 405 1.210 329
2025/20267.212 834 415 628 625 1.259 307 970 410 894 514 184 172
2026/2027175 148 27 0 0 0 0 0 0 0 0 0 0
Totale 17.005